Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) Other Accumulated Expenses (2013)

Bone Biologics (BBLGW) posted quarterly Other Accumulated Expenses of $75000.0 for Q4 2013.

Bone Biologics Corp (BBLGW) Other Accumulated Expenses (2013) Analysis & Trends

Bone Biologics (BBLGW) has reported Other Accumulated Expenses for 1 consecutive years, with $75000.0 the latest figure, recorded in Q4 2013.

  • In Q4 2013, Other Accumulated Expenses changed N/A year-over-year to $75000.0; the TTM figure through Dec 2013 stood at $75000.0 (changed N/A YoY), while the FY2013 annual figure was $75000.0, changed N/A from the prior year.
  • Other Accumulated Expenses was little changed at $75000.0 in Q4 2013 per BBLGW's latest filing.
  • Across five years, Other Accumulated Expenses topped out at $75000.0 in Q4 2013 and bottomed at $75000.0 in Q4 2013.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2013 75,000.00